HRT FINANCIAL LP

Position in GILD — Gilead Sciences, Inc.

CIK 1475597 NEW YORK, NY

Position in GILD

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$37,727,319

+$26,108,949 QoQ

Shares Held

270,699

+158.6% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. GILD ranks #5 (6.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	926,410	$201,484,910
2	BMY	Bristol Myers Squibb Co	2,075,945	$125,906,064
3	AMGN	Amgen Inc	321,715	$113,195,422
4	LLY	ELI LILLY & Co	53,051	$48,794,718
5	GILD	Gilead Sciences, Inc. This page	270,699	$37,727,319
6	GSK	GSK plc	425,687	$23,493,665
7	MRK	Merck & Co., Inc.	142,729	$17,168,871
8	NVS	Novartis AG	24,886	$3,801,336

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$37,727,319	270,699	+158.6%	Shares	Defined	2026-05-14
2025-09-30	$11,618,370	104,670	-92.0%	Shares	Defined	2025-11-14
2025-03-31	$146,866,848	1,310,726	+7.1%	Shares	Defined	2025-05-15
2024-09-30	$102,649,587	1,224,351	+1948.1%	Shares	Defined	2024-11-12
2024-03-31	$4,378,811	59,779	+1204.1%	Shares	Defined	2024-05-13
2023-09-30	$343,524	4,584	-98.4%	Shares	Defined	2023-11-13
2023-03-31	$24,127,510	290,798	-1.9%	Shares	Defined	2023-05-12
2022-12-31	$25,447,227	296,415	+385.8%	Shares	Defined	2023-02-10
2022-03-31	$3,627,579	61,019	-30.0%	Shares	Defined	2022-05-16
2020-12-31	$5,081,845	87,227	+109.1%	Shares	Defined	2021-02-16
2020-06-30	$3,209,629	41,716	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.